| ID | Sequence | Length | GC content |
|---|---|---|---|
| OIP5-AS1:4 | AGGGUUGGCCACCUUGAGAAGCUGCGAAGAUGGCGGAGUAAGGCGUGCC… | 1269 nt | 0.4815 |
| OIP5-AS1:5 | AGGGUUGGCCACCUUGAGAAGCUGCGAAGAUGGCGGAGUAAGGCGUGCC… | 676 nt | 0.4260 |
| OIP5-AS1:6 | UUGAGAAGCUGCGAAGAUGGCGGAGUAAGGCGUGCCGCUGCAAACUGGC… | 1893 nt | 0.4337 |
| OIP5-AS1:7 | UUGAGAAGCUGCGAAGAUGGCGGAGUAAGGCGUGCCGCUGCAAACUGGC… | 1894 nt | 0.4335 |
| OIP5-AS1:8 | UGAGAAGCUGCGAAGAUGGCGGAGUAAGGCGUGCCGCUGCAAACUGGCC… | 249 nt | 0.5663 |
| OIP5-AS1:9 | GAGAAGCUGCGAAGAUGGCGGAGUAAGGCGUGCCGCUGCAAACUGGCCU… | 4265 nt | 0.4007 |
This is a conserved gene that produces a long non-coding RNA that maintains cell proliferation in embryonic stem cells. This RNA can bind to and negatively regulate the activity of multiple cellular RNAs and microRNAs, including cyclin G associated kinase and ELAV like RNA binding protein 1. [provided by RefSeq, Dec 2017]
A study in humans identified the OIP5-AS1 as a hub long non-coding RNA within a constructed ceRNA network for sepsis, having the highest degree distribution and being part of regulator pairs used for drug prediction [Wang et al. DOI:10.1016/j.heliyon.2024.e27379]. In a separate investigation of sepsis-induced acute respiratory distress syndrome, the OIP5-AS1 was noted as a potential regulator that modulates GPR65 expression through specific miRNAs and worsens LPS-induced acute lung injury/ARDS [Liu et al. DOI:10.3389/fimmu.2025.1528769].